Clinical Trials Directory

Trials / Completed

CompletedNCT00073619

Preventing Anxiety Disorders in Urban Youth

Community Violence and Youth: Preventing Anxiety Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Accepted

Summary

This study will determine the effectiveness of a cognitive-behavioral group therapy program in preventing anxiety disorders in at-risk children exposed to community violence.

Detailed description

Community violence is a major public health problem in low-income, urban communities. The mental health impact of living in a violent community is significant, particularly for children. Community violence exposure is associated with various symptoms of anxiety. Unfortunately, little research on the prevention of community-related anxiety in youth has been conducted. This study involves a school-based prevention and cognitive behavioral therapy program that will involve predominantly African American children who live in urban areas and are at risk for developing anxiety disorders. Children in this study will be randomly assigned to either an anxiety prevention and early intervention group or a nonintervention group for approximately 3 months. Child, parent, and teacher assessments of anxiety symptoms will be made at the end of the study and at a 6-month follow-up visit.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive-behavioral group therapySchool-based anxiety preventive intervention (cognitive-behavioral group therapy) originally designed for Australian children that was culturally and contextually modified for inner-city children exposed to community violence. Participants received the weekly intervention and rewards for participating in the assessments.

Timeline

Start date
2001-12-01
Primary completion
2007-07-01
Completion
2011-07-01
First posted
2003-12-03
Last updated
2016-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00073619. Inclusion in this directory is not an endorsement.